Los Angeles Capital Management LLC Reduces Position in Maximus, Inc. (NYSE:MMS)

Los Angeles Capital Management LLC lessened its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 76.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,683 shares of the health services provider's stock after selling 12,285 shares during the period. Los Angeles Capital Management LLC's holdings in Maximus were worth $275,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Nordea Investment Management AB bought a new stake in Maximus in the 4th quarter valued at approximately $4,618,000. Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after acquiring an additional 83,390 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Maximus in the 4th quarter valued at $1,113,000. Versor Investments LP grew its holdings in Maximus by 213.5% in the 3rd quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock valued at $792,000 after buying an additional 5,789 shares in the last quarter. Finally, Legato Capital Management LLC grew its holdings in Maximus by 33.9% in the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after buying an additional 8,138 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on MMS shares. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Remove Ads

Insiders Place Their Bets

In related news, Director Raymond B. Ruddy bought 3,490 shares of the company's stock in a transaction dated Thursday, December 12th. The shares were bought at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the acquisition, the director now directly owns 112,520 shares of the company's stock, valued at $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Bruce Caswell bought 3,500 shares of the company's stock in a transaction dated Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 7,008 shares of company stock worth $497,835. Corporate insiders own 1.60% of the company's stock.

Maximus Trading Up 4.8 %

Shares of MMS stock traded up $3.25 on Friday, hitting $71.26. The company had a trading volume of 871,938 shares, compared to its average volume of 475,956. The firm has a market cap of $4.03 billion, a P/E ratio of 15.33 and a beta of 0.71. The stock's 50-day moving average is $72.80 and its two-hundred day moving average is $80.41. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.68%. Maximus's dividend payout ratio is currently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.